SIN13775P Medication Singapore | Medicine SG
SIN13775P is the Singapore licence number of the medication Synflorix Suspension for Injection (Prefilled Syringe), held by GLAXOSMITHKLINE PTE LTD, approved on 1970-01-01. The dosage in INJECTION, SUSPENSION form, is administered by the INTRAMUSCULAR route. The forensic classification is Prescription Only, and ATC code is J07AL52.
Permalink: https://www.medicinesg.com/sg/meds/sin13775p/
- Licence number: SIN13775P
- Product name: Synflorix Suspension for Injection (Prefilled Syringe)
- License holder: GLAXOSMITHKLINE PTE LTD
- Approval date: 1970-01-01
- Forensic classification: Prescription Only
- ATC Code: J07AL52
- Dosage form: INJECTION, SUSPENSION
- Route of Administration: INTRAMUSCULAR
- Manufacturer & Country of manufacturer:
- Active ingredients & Strength:
- Conjugate of Streptococcus pneumoniae type 1 & Haemophilus influenzae protein D – 1 μg PS1; 1.11-1.67 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 14 and Haemophilus influenzae protein D – 1 μg PS14; 1.00-1.82 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 18C and tetanus toxoid – 3 μg PS18C; 5.45-10.00 μg TT/dose
- Conjugate of Streptococcus pneumoniae type 19F and diphtheria toxoid – 3 μg PS19F; 3.33-6.00 μg DT/dose
- Conjugate of Streptococcus pneumoniae type 23F and Haemophilus influenzae protein D – 1 μg PS23F; 0.39-0.74 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 4 and Haemophilus influenzae protein D – 3 μg PS4; 3.33-6.67 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 5 and Haemophilus influenzae protein D – 1 μg PS5; 0.67-1.25 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 6B and Haemophilus influenzae protein D – 1 μg PS6B; 0.56-0.95 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 7F and Haemophilus influenzae protein D – 1 μg PS7F; 0.87-1.43 μg PD/dose
- Conjugate of Streptococcus pneumoniae type 9V and Haemophilus influenzae protein D – 1 μg PS9V; 1.00-1.82 μg PD/dose
- Diphtheria Toxoid (DT) Carrier Protein – 3-6 μg DT/dose (total DT content)
- Polysaccharide (PS) – 16 μg/dose (total PS content)
- Protein-D (PD) Carrier Protein (derived from non-typeable Haemophilus influenzae) – 9-16 μg PD/dose (total PD content)
- Tetanus Toxoid (TT) Carrier Protein – 5-10 μg/dose (total TT content)